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chapter 5
Nestin, c-met, and c-kit 





Objective: Nestin, c-met, and c-kit, positive cells are found in the developing or 
regenerating pancreas and less in the adult pancreas in homeostasis. However, little 
is known about the characteristics of these cells. 
Research Design and Methods: We investigated the expression of genes involved in 
pancreas development (c-met, c-kit, nestin, Beta2, Islet-1, Pax6, Pax4, Pdx-1, ngn3, 
Glut-2, insulin, glucagon and amylase). Next we performed immunoÀ uorescent 
staining of nestin, c-met, and c-kit with proteins associated with the early (islet-1), 
mid- (ngn3), or late (Pax 4) stage of beta-cells differentiation. We also studied 
the differential capacity of these cells into endothelial (CD31) and nerve cells 
(ȕ3-tubulin). 
Results: Nestin is expressed by beta-cells in the early and mid-stage of 
differentiation and is absent on beta-cells at the late or end stage of differentiation. 
C-met and c-kit are receptors that are found on all stages of differentiation of beta-
cells. Furthermore, in the islets of Langerhans, nestin, c-met and c-kit positive cells 
also express pancreatic polypeptide, somatostatin, CD31 and ȕ3-tubulin. 
Conclusions: In the pancreas heterogenous population of nestin, c-met and c-kit 
positive cells exist. These cells are indeed precursors for beta-cells; however a 
portion also contributes to vessel and nerve formation.
INTRODUCTION
The neonatal rat pancreas has the ability to form a complete adult pancreas in 
a period of not more than three weeks [1,2]. This unique ability of the neonatal 
pancreas is under the guidance of a number of cell types. Among these cells 
types are a population of cells expressing nestin [3], the receptor for hepatocyte 
growth factor (HGF); c-met [4,5], and the receptor for the stem cell growth factor 
(c-kit) [1,2,4-6]. These proteins and receptors are found in the developing or 
regenerating pancreas and less in the adult pancreas in homeostasis [1-6]. Cells 
expressing these proteins are of interest for understanding the growth mechanisms 
of the pancreas and may even have therapeutic consequences as they may serve 
as target for induction of regeneration of the pancreas such as in some forms 
of type II Diabetes. 
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Nestin expression has been mainly associated with beta-cell formation. It has been 
described that nestin positive cells differentiate in vitro into endocrine cells that 
produce insulin, glucagon, glucagon like peptide-1 (GLP-1), and the transcription 
factor Pdx-1 [3]. A group of these nestin positive cells carry the c-met receptor and 
have been associated with pancreatic development [5,7,8] and its ligand hepatic 
growth factor (HGF) is associated with beta-cell differentiation [8-12]. C-met 
positive cells in the pancreas are considered to be multipotent and able to form 
cells of different pancreatic lineages. It was also shown that some c-met positive 
cells can be clonally expanded and therefore qualify as organ bound stem cell [5].
C-kit expressing cells in the pancreas are associated with neogenesis and 
reported to be expressed in the prenatal and postnatal rat pancreas, and during 
islet-cell development [1,6] and regeneration. Downregulation of c-kit results in 
decreased pdx-1 and insulin expression, suggesting downregulation of beta-cell 
differentiation [13]. 
Although nestin, c-met, and c-kit expression is associated with beta-cell 
development, it has never been shown that these proteins are expressed on beta-
cells during differentiation or at which stage of beta-cells differentiation these 
proteins are expressed on beta-cells. We therefore ¿ rst isolated nestin, c-kit 
and c-met positive cells from the neonatal pancreas and studied expression of 
transcription factors associated with pancreatic and beta-cell development in these 
cells. As the neonatal pancreas contains populations of beta-cells in different stages 
of development, we next studied the expression of nestin-, c-met, and c-kit on 
beta-cells in neonatal islets. Also, in a subsequent study we determined whether the 
expression was restricted to beta-cells or also occurs in differentiating pancreatic 
cells of non-beta-cell origin.
MATERIALS AND METHODS
Design of study
In order to decide upon the panel of transcription factors we should screen for 
on a protein levels we ¿ rst applied a broad gene pro¿ le of nestin, c-met, and 
c-kit, positive cells isolated from the neonatal pancreas by RT-PCR assessments. 
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We quanti¿ ed the mRNA levels of c-met, c-kit, nestin, Beta2 (transcription 
factor associated with beta-cell formation), Islet-1 (transcription factor speci¿ c 
for endocrine cell formation), Pax6 (transcription factor speci¿ c for alpha-cell 
formation), Pax4 (transcription factor speci¿ c for beta- and delta-cell formation), 
Pdx-1 (transcription factor speci¿ c for beta-cell formation), ngn3 (transcription 
factor speci¿ c for endocrine cell formation), Glut-2 (glucose transporter expressed 
by beta-cell), insulin (beta-cell secreted hormone), glucagon (alpha-cell secreted 
hormone), and amylase (acinar cell secreted enzyme). A selection of these proteins 
was applied in the subsequent immunoÀ uorescent study in which we determined 
the expression of nestin, c-met, and c-kit on neonatal islets with beta-cells in either 
the early, mid-, or late stage of differentiation.
To study whether nestin, c-met, and c-kit cells is restricted to beta-cells or can 
also be found in other pancreatic cell types we studied the co-expression of nestin, 
c-met, and c-kit with the following markers; insulin or pdx-1 (beta-cells), glucagon 
(alpha-cells), pancreatic polypeptide (PP-cells) and somatostatin (delta-cells), 
CD31 (endothelial cells), and ȕ3-tubulin (nerve cells).
Animals
All experiments were conducted in accordance with NIH-guidelines for the care 
and use of laboratory animals. Female Wistar rats (Harlan; age 3-4 months and 
weighing ~200 g) were kept in a temperature- and light-controlled room (lights on 
from 6 AM to 6 PM). 
Animals to obtain pregnancy were subjected to daily vaginal smears. Pregnancy 
was achieved by housing the female rats on the night of pro-oestrus with a fertile 
male for one night. Rats were made pregnant and allowed to deliver naturally. 
Neonatal rats were used 1-2 days after delivery.
Surgery
The neonatal rat pancreata were obtained from 1-2 days old rat pups. The pups 
were decapitated and the pancreas was surgically removed. This was done by 
laparotomy, replacing the stomach aside, and taking the pancreas out by cutting 
it loose from the spleen, duodenum, and stomach wall. The neonatal pancreata 
were either snap frozen in liquid nitrogen and stored at -80ºC until sectioning or 
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processed for cell-isolation. For cell-isolation, the pancreata were stored in 5 ml 
of 0.20m ¿ ltered Krebs-Ringer-Hepes buffer (KRH: 133 mM NaCl, 4.69 mM 
KCl, 1.18 mM KH2PO4, 1.18 mM MgSO4.7H2O, 10 mM HEPES and 2.52 mM
 
CaCl2.2H2O (pH 7.4)) containing 5% bovine serum albumin (BSA) on ice.
Cell-isolation
Neonatal pancreata were digested with collagenase to transform them into single 
cells. The pancreata were ¿ rst cut in small fragments of approximately 1 mm. The 
fragments were then washed once with KRH containing 5% BSA for 5 minutes 
at 4ºC. The pancreas fragments were digested with 5.5 mg/ml Collagenase P 
(Boehringer Mannheim, Germany) in KRH containing 1% BSA for 12 minutes at 
37ºC under continuous agitation in a water bath. For the separation of the single 
cells from the debris, the mixture was centrifuged at 500 rpm for 30 seconds at 
20ºC. The supernatant (containing the single cells) was aspired. The single cell 
suspension was washed 3 times with KRH containing 1% BSA for 5 minutes at 
4ºC. After washing, the cells were resuspended in KRH containing 1% BSA. Cell 
viability was determined with Trypan blue dye exclusion. The viability was always 
above 90%. After this procedure the single cells were divided in a portion for 
nestin, c-met, or c-kit cell-sorting.
According to standard methods the following procedure was performed for cell-
sorting. First the single cells were centrifuged at 1500 rpm for 5 minutes. The 
supernatant was discarded and the pellet was pre-incubated with undiluted swine 
serum for 30 minutes. After incubation the cells were washed with PBS containing 
0,5% BSA and 0,1% sodiumazide. Subsequently, the mixture was centrifuged at 
1500 rpm for 5 minutes. Next the cells were incubated with the primary antibody 
anti-c-met (1:100) (H-190, Santa Cruz Biotechnology) or anti-c-kit (1:100) (C-19, 
Santa Cruz Biotechnology) for 60 minutes. Then the cells were incubated with 
secondary antibody swine-anti-rabbit FITC (1:50) (DakoCytomation, Denmark) 
for 30 minutes in the dark. After incubation the cells were washed with PBS 
for 5 minutes and resuspended in PBS. For cell-sorting of nestin positive cells 
we had to perform a different procedure since nestin is an intracellular protein. 
Therefore the single cell suspension was ¿ rst permeabilised with PBS containing 
0,5% saponin for 15 minutes and subsequently washed with PBS for 5 minutes. 
The cells were then incubated with primary antibody nestin (1:200) (Clone 401, 
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BD Biosciences), for 60 minutes. After incubation the cells were washed with 
PBS for 5 minutes. Finally, the cells were incubated with goat-anti-mouse-FITC 
(1:50) (Southern Biotechnology Associates, Inc). After incubation the cells were 
washed with PBS for 5 minutes and resuspended in PBS. The whole procedure was 
performed on ice. Positive selection for nestin, c-met and c-kit was performed using 
a Fluorescence Activated Cell Sorter (FACS, MoFlo À ow cytometer) (Cytomation, 
USA). The sorted cells were collected in a tube with sterile RPMI 1640 containing 
10% FCS, and 10 mg/ml Gentamycin (GIBCO). After cell sorting we examined the 
purity of the populations and we only included experiments where the purity of the 
populations were higher than 90%.
Transformation of isolated islets into single cells suspension
Islets of neonatal rat pancreata were isolated according to a collagenase digestion 
method as previously described. BrieÀ y, islet isolation was performed in 
KRH containing 10% BSA. The pancreata were chopped in small fragments of 
1 mm2. Next the fragments were washed 3 times in KRH containing 10% BSA. 
Subsequently, the pancreas was digested using a two stage incubation of 20 min 
at 37oC with successively 1.0 and 0.7 mg/ml collagenase (Sigma type XI, Sigma, 
St Louis, MO, USA). Islets were separated from exocrine tissue by centrifugation 
over a discontinuous dextran gradient and further puri¿ ed by handpicking. Islets 
were collected and washed in PBS twice before being dispersed into single cells 
by mechanical shaking at 37ºC for 3 minutes in 0.05% Trypsin, 0.5 mM EDTA 
(Gibco). The enzymatic reaction was stopped by adding KRH 10% BSA. Cell 
viability was determined with Trypan blue dye exclusion indicated that more than 
95% of the cells were viable after the procedure. Islets single cells were spotted on 
glass slides at a density of 50.000 cells per slide. This was done with a Cytospin 
centrifuge at 500 rpm for 5 min. Tissue cryosections were air dried and stored at 
-20ºC until staining.
RNA isolation and cDNA synthesis
Sorted cells were washed with PBS. Total RNA was isolated using an Absolutely 
RNA® Miniprep kit (Stratagene, Netherlands) according to the manufacturer’s 
protocol. BrieÀ y, the cells were lysed in the lysisbuffer provided in the kit. 
Ethanol (70%) was added and the solution was placed in a RNA-Binding Spin Cup 
(containing a silica-based ¿ ber matrix). The RNA binds to the silica-based ¿ ber 
Nestin, c-met, and c-kit expression in differentiating neonatal beta-cells
89
matrix. Possible genomic DNA contamination was removed by incubation with 
RNase-Free DNase I and DNase Digestion Buffer (Stratagene). Several washing 
steps removed contaminants and the RNA was collected using an elution buffer. RNA 
concentration was measured using The NanoDrop® ND-1000 Spectrophotometer. 
The cDNA was synthesized from total RNA using SuperScript III reverse 
transcriptase (Invitrogen), RNaseOUT Recombinant Ribonuclease Inhibitor 
(Invitrogen), 0.1M DTT (Invitrogen), 5x First Strand Buffer (Invitrogen), dNTPs 
and random hexamer primers (Invitrogen) according to manufacturer’s protocol. 
Polymerase Chain Reaction analysis
PCR reactions were performed in a MJ Research PTC-100 Thermal Cycler. The 
PCR reaction (total 30 ȝl) was performed as follows: 100 ng cDNA, 3 ȝl 10x 
PCR buffer (Fermentas), 3 ȝl dNTP’s (2mM, Fermentas), 1.25 ȝl MgCl2 (50mM, 
Fermentas), 0.2 ȝl Taq DNA Polymerase (Invitrogen), 1 ȝl forward primer (40 mM), 
1 ȝl reverse primer (40mM) and MilliQ water add up to 30 ȝl. 
PCR cycles were as follows: denaturation of the double-stranded DNA at 94ºC 
for 5 minutes, followed by 94ºC for 30 seconds, primer annealing temperature for 
30 seconds, 72ºC for 30 seconds (40 cycles), and ¿ nal extension at 72ºC for 
5 minutes. The PCR products were separated on a 2% agarose gel in 0.5x TBE 
running buffer (150V, 60 minutes), and visualized by ethidium bromide staining. 
The primer sequences, annealing temperatures, and the expected fragment sizes are 
shown in Table 1. ȕ-Actin was used as a housekeeping gene for the PCR reaction.
ImmunoÀ uorescence on sections of neonatal pancreata 
Neonatal pancreata were sectioned at 4 ȝm and then ¿ xed in acetone for 10 minutes, 
followed by air drying for 30 minutes. The whole procedure was performed at room 
temperature. 
For double staining of islet-1, ngn3, or amylase with c-met or c-kit the sections 
were treated as follows. The sections were incubated with normal donkey serum 
for 30 minutes and subsequently blocked with a biotin blocking system kit 
(DakoCytomation, Carpinteria, CA) for 15 minutes. Then the sections were incubated 
with primary antibody anti-islet-1(1:400) (K-20, Santa Cruz Biotechnology) anti-
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ngn3 (1:400) (A-19, Santa Cruz Biotechnology), anti-amylase (1:400) (C-20, Santa 
Cruz Biotechnology) for 60 minutes; followed by secondary antibody Donkey-anti-
goat-FITC (1:100) (AP180F, Chemicon International). Subsequently, the sections 
were incubated with normal goat serum for 30 minutes. Next the sections were 
incubated with primary antibody anti-c-met (1:150) or anti-c-kit (1:100) for 60 
minutes. Then the sections were incubated with secondary antibody goat-anti-
rabbit biotin (1:50) (DakoCytomation, Denmark) followed by tertiary antibody 
streptavidin-Cy3 (1:200) (Zymed laboratories, Inc) incubation for 30 minutes.
For double staining of islet-1, ngn3, or amylase with nestin the sections were treated 
as follows. The sections were incubated with normal donkey serum for 30 minutes. 
Then the sections were incubated with primary antibody anti-nestin (1:100) for 
60 minutes; followed by secondary antibody Donkey-anti-mouse-TRITC (1:100) 
(AP192R, Chemicon International). Subsequently, the sections were incubated 
with normal donkey serum for 30 minutes. Next the sections were incubated with 
primary antibody anti-islet-1(1:400) anti-ngn3 (1:400), anti-amylase (1:400) for 
60 minutes. Finally, the sections were incubated with secondary antibody Donkey-
anti-goat-FITC (1:100).
For double staining of Pax6 with c-met or c-kit the sections were treated as 
follows. The spots were incubated with normal goat serum for 30 minutes and 
subsequently blocked with a biotin blocking system for 15 minutes. Next the 
sections were incubated with primary antibody anti-Pax6 (1:400) (sc-53108, Santa 
Cruz Biotechnology) for 60 minutes. After that the sections were incubated with 
secondary antibody goat-anti-rabbit biotin (1:50) followed by tertiary antibody 
streptavidin-Cy3 (1:200) incubation for 30 minutes. Subsequently, the sections 
were incubated with primary antibody anti-c-met (1:150) or anti-c-kit (1:100) for 
60 minutes. Next the spots were incubated with secondary antibody swine-anti-rabbit 
(FITC) (1:50) for 30 minutes followed by tertiary antibody goat-anti-swine (FITC) 
(1:50) (Jackson ImmunoResearch Laboratories, Inc) incubation for 30 minutes. 
Finally the sections were incubated with 4’, 6-diamidino-2-phenylindole (DAPI) 
(1:2500) for 10 minutes and mounted with CitiÀ uor. Due to technical reasons, 
c-met and c-kit could not be doubled stained for Pax4. 
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For double staining of Pax4 or Pax6 with nestin the sections were treated as follows. 
The sections were incubated with normal donkey serum for 30 minutes. Then the 
sections were incubated with primary antibody anti-nestin (1:100); followed by 
secondary antibody donkey-anti-mouse-FITC (1:100) or donkey-anti-mouse-
TRITC (1:100). Subsequently, the sections were incubated with normal goat serum 
for 30 minutes blocked with a biotin blocking system kit for 15 minutes. Next 
the sections were incubated with primary antibody anti-Pax4 (1:150) (M-20, Santa 
Cruz Biotechnology) or anti-Pax6 (1:400) (sc-53108, Santa Cruz Biotechnology) 
for 60 minutes. After that the sections were incubated with secondary antibody 
goat-anti-rabbit biotin (1:50) followed by tertiary antibody streptavidin-FITC 
(1:100) or streptavidin-Cy3 (1:200) incubation for 30 minutes. Finally the sections 
were incubated with 4’,6-diamidino-2-phenylindole (DAPI) (1:2500) (Roche) for 
10 minutes and mounted with CitiÀ uor (Agar Scienti¿ c). Analysis was performed 
using the Leica DMRXA À uorescent microscope and Leica Qwin Pro software.
ImmunoÀ uorescence on cytospots of islet cells
Cytospots were air dried and then ¿ xed in acetone for 10 minutes, followed by air 
drying for 30 minutes. The whole procedure was performed at room temperature. 
For double staining of c-met or c-kit with insulin or glucagon and Polypeptide 
and Somatostatin with nestin the spots were treated as follows. The spots were 
incubated with normal goat serum for 30 minutes and subsequently blocked with a 
biotin blocking system kit for 15 minutes. Subsequently, the sections were incubated 
with primary antibody anti-c-met (1:150) or anti-c-kit (1:100) or anti-PP (Abcam) 
1:600, anti-Somatostatin (Sigma Aldrich) 1:800) for 60 minutes. Next the spots 
were incubated with secondary antibody goat-anti-rabbit biotin (1:50) followed 
by tertiary antibody streptavidin-Cy3 (1:200) incubation for 30 minutes. Then the 
spots were incubated with primary antibody anti-insulin (1:750) (Sigma-Aldrich, 
The Netherlands), or anti-glucagon (1:2000) (Sigma-Aldrich, The Netherlands), or 
anti-nestin (1:500); followed by secondary antibody goat-anti-mouse-FITC (1:50). 
Since the antibodies of c-met, c-kit and Polypeptide and Somatostatin are of the 
same isotype we could not perform the double staining for these proteins. Also the 
antibodies of nestin and glucagon are of the same isotype therefore we could not 
perform the double staining for these two proteins. In addition, the double staining 
of nestin and insulin could also not be done, because the antibodies are of the same 
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isotype. Since it is important for the line of reasoning (vide infra) to determine 
whether nestin positive cells have feature of beta-cells we decided to perform a 
staining for nestin with Pdx-1. For double staining of Pdx-1 or ȕ3-tubulin with nestin 
the spots were treated as follow: the spots were incubated with normal goat serum for 
30 minutes at room temperature and subsequently blocked with the biotin blocking 
system kit for 15 minutes. Subsequently, the spots were incubated with primary 
antibody anti-Pdx-1 (P9995, Sigma Aldrich Inc.,) (1:100), or anti- ȕ3-tubulin (gift 
from Dr. W. Baron) for 60 minutes. Next the spots were incubated with secondary 
antibody goat-anti-rabbit biotin (1:50) followed by tertiary antibody streptavidin-
Cy3 (1:200) or goat-anti-mouse-tetramethyl rhodamine iso-thiocyanate (TRITC) 
(1:50) (DakoCytomation, Denmark) incubation for 30 minutes. Then the spots 
were incubated with primary antibody anti-nestin (1:100); followed by secondary 
antibody goat-anti-mouse-FITC (1:50). The whole procedure was performed at 
room temperature. 
For double staining of c-met or c-kit with ȕ3-tubulin the spots were treated as 
follows. The spots were incubated with normal goat serum for 30 minutes and 
subsequently blocked with the biotin blocking system kit for 15 minutes. 
Subsequently, the spots were incubated with primary antibody anti-c-met 
(1:150) or anti-c-kit (1:100) for 60 minutes. Next the spots were incubated with 
secondary antibody goat-anti-rabbit biotin (1:50) followed by tertiary antibody 
streptavidin-Cy3 (1:200) or goat-anti-mouse-FITC (1:50) incubation for 
30 minutes. 
For double staining of nestin, c-met, or c-kit with CD31 we followed the 
following procedure. The spots were incubated with normal goat serum for 
30 minutes and subsequently blocked with a biotin blocking system for 
15 minutes. Subsequently, the spots were incubated with primary antibody 
anti-nestin (1:100) or anti-c-met (1:150) or anti-c-kit (1:100) for 60 minutes. 
Next the spots were incubated with secondary antibody goat-anti-mouse IgG1 
À uorescein isothiocyanate FITC (1:50) (for nestin) or goat-anti-rabbit biotin 
(1:50) (for c-met) or swine-anti-rabbit (FITC) (1:50) (for c-kit) for 30 minutes 
followed by tertiary antibody streptavidin-Cy3 (1:200) or goat-anti-swine 
(FITC) (1:50) (Jackson ImmunoResearch Laboratories, Inc) incubation for 
30 minutes. Then the spots were incubated with primary antibody anti-CD31-
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biotinylated (1:50) for 60 minutes. Subsequently, the spots were incubated with 
secondary antibody streptavidin-Cy3 (1:200) for 30 minutes. Finally the spots were 
incubated with 4’, 6-diamidino-2-phenylindole (DAPI) (1:2500) for 10 minutes 
and mounted with CitiÀ uor. Analysis was performed using the Leica DMRXA 
À uorescent microscope equipped with Leica DC 350 FX and Leica Qwin Pro 
software.
RESULTS
Although it has been shown that cells expressing nestin, c-met, and c-kit expression 
are essential for normal development of the pancreas, minor knowledge is available 
about the frequency of the cells expressing these proteins, the expression of 
transcription factor associated with development of the pancreas in these cells, and 
to which cell-types these cells will differentiate in vivo. We started out by isolating 
pure and fresh populations of these cells from the neonatal pancreas, which allowed 
us the study the expression of mRNA of various transcription factors associated 
with pancreatic development.
After transforming neonatal pancreata into single cells, we found that 25,0 ± 1,7% 
of the cell population are nestin positive, 1,8 ± 0,9% are c-met positive cells, and 
4,7 ± 0,8% are c-kit positive cells (Table 1). These individual populations were 
puri¿ ed by cell sorting. Because it is dif¿ cult to isolate suf¿ cient amounts of RNA 
from permeabilised intracellularly stained nestin positive cells, we could only 
quantify a limited number of genes. As nestin has been mostly described as a protein 
associated with endocrine cells we choose the transcription factors ngn3, Pax4, and 
Pdx-1. We found that nestin positive cells expressed ngn3, but not Pax4, or Pdx-1 
(Figure 1A). The sorted c-met or c-kit positive cells were subjected to a broader 
analysis, since we could obtain more RNA from these cells after cell-sorting. We 
quanti¿ ed the mRNA levels of c-met, c-kit, nestin, Beta2, Islet-1, Pax6, Pax4, 
Pdx-1, ngn3, Glut-2, insulin, glucagon, and amylase. C-met sorted cells express 
c-met, c-kit, nestin, Beta2, Pax6, ngn3, Pdx-1, insulin, glucagon, and amylase on 
mRNA levels (Figure 1B). C-kit sorted cells express c-kit, Beta2, Islet-1, Pax4, 
insulin, and amylase on mRNA levels (Figure 1C).
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Table 1: Percentage of nestin, c-met, and c-kit positive cells in the neonatal pancreas.
Cells in the neonatal pancreas Percentage of positive cells
Nestin positve cells 25,0 ± 1,7
C-met positive cells 1,8 ± 0,9
C-kit positive cells 4,7 ± 0,8
Transcription factors in the endocrine and exocrine tissues
From the above follows that c-met, c-kit and nestin positive cells express 
various transcription factors associated with beta-cell development. By sorting 
cells from the whole pancreas, we sorted a heterogenous population of c-kit, 
c-met, and nestin positive cells, since these cells can be found not only in 
islets but also around the ducts and vasculature as well as in exocrine tissue 
(chapter 4). Therefore, we next studied in histological sections which of the cell 
populations expressed the beta-cell speci¿ c transcription factors.
We performed double staining with an early, mid and late markers for endocrine 
cell differentiation and an exocrine marker. We de¿ ne islet-1 as an early-
stage protein for endocrine differentiation [14], ngn3 as a mid-stage protein for 
endocrine differentiation [14], and Pax4 or Pax6 as late-stage proteins for beta-
cell differentiation and delta-cell differentiation [14]. We studied in nestin positive 
cells islet-1, ngn3, Pax4, or Pax6, and in c-met and c-kit positive cells islet-1, 
ngn3, and Pax6, on a protein level. Due to technical reasons (see materials and 
methods), c-met and c-kit could not be doubled stained for Pax4. We furthermore 
investigated whether nestin, c-met, and c-kit cells also expressed the late exocrine 
marker amylase [15].
Nestin positive cells were abundantly present in both the exocrine and endocrine 
pancreas. The nestin positive cells in the endocrine pancreas, i.e. the islets, co-
express islet-1 (Figure 2A) and ngn3 (Figure 2B), the early and late stage markers 
for beta-cells. We furthermore found that nestin positive cells do not co-express 
Pax4 (Figure 2C) or Pax6 (Figure 2D), i.e. transcription factors associated with 
beta-cell and alpha-cell formation. Surprisingly, although we found nestin positive 
cells in the exocrine pancreas, the cells never expressed amylase (Figure 2E).
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Figure 1: Agarose gel electroforesis of RT-PCR products of freshly isolated nestin,c-met, 
and c-kit positive cells. Nestin, c-met, and c-kit positive cells were isolated from neonatal 
pancreata and following RNA isolation and cDNA synthesis subjected to RT-PCR. Nestin 
positive cells were checked for the gene transcripts of Pax4, Ngn3 and Pdx-1; and c-met 
and c-kit positive cells were checked for the gene transcripts of c-met, c-kit, nestin, Beta2, 
Islet-1, Pax6, Pax4, Pdx-1, ngn3, Glut-2, insulin, glucagon, and amylase. B-actin was 
used as a housekeeping gene. Note that nestin positive cells express Ngn3 and not the 
late genes for Pax4 or Pdx-1 (A). C-met positive cells express c-met, c-kit, nestin, Pax6, 
Pdx-1, insulin, glucagon, and amylase, but not Islet-1, Pax4, Glut-2 on mRNA levels 
(B). C-kit positive cells express c-kit, Pax4, insulin, and amylase, but no c-met, nestin, 
Pax6 ngn3, Pdx-1, Glut-2 or glucagon on mRNA levels (C).
C-met positive cells were found as scattered spots throughout both the endocrine 
and exocrine pancreas. C-met is clearly expressed in the whole period of beta-
cell differentiation as it was found on cells expressing islet-1 (Figure 3A), ngn-3 
(Figure 3B) and Pax-6 (Figure 3C). Notably we found that c-met positive cells 
were negative for islet-1 mRNA. C-met expression was also found on amylase 
producing exocrine cells (Figure 3D).
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Figure 2: Photomicrograph of the neonatal rat pancreas after immunostaining for nestin 
with the early, mid and late markers for endocrine cell differentiation and the late exocrine 
marker. The sections were immunostained for nestin with Islet-1, nestin with ngn3, nestin 
with Pax4, nestin with Pax6, and nestin with amylase. Nestin positive cells in the islets of 
the neonatal pancreas co-express islet-1 (A) and ngn3 (B), but not Pax4 (C), Pax6 (D) or 
amylase (E). Original magni¿ cation 200X
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Figure 3: Photomicrograph of the neonatal rat pancreas after immunostaining for 
c-met with the early, mid and late markers for endocrine cell differentiation and the late 
exocrine marker. The sections were immunostained for c-met with Islet-1, c-met with 
ngn3, c-met with Pax4, c-met with Pax6, and c-met with amylase (E). C-met positive cells 
in the islets of the neonatal pancreas co-express islet-1 (A), ngn3 (B), Pax4 (C), Pax6 (D) 
and amylase (E). Original magni¿ cation 200X
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Figure 4: Photomicrograph of the neonatal rat pancreas after immunostaining for c-kit 
with the early, mid and late markers for endocrine cell differentiation and the late exocrine 
marker. The sections were immunostained for c-kit with Islet-1, c-kit with ngn3, c-kit with 
Pax4, c-kit with Pax6, and c-kit with amylase (E). C-kit positive cells in the islets of the 
neonatal pancreas co-express islet-1 (A), ngn3 (B), Pax4 (C), Pax6 (D) and amylase (E). 
Original magni¿ cation 200X
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Also c-kit expression can be found in all stages of beta-cell differentiation. C-kit 
was found on cells expressing islet-1 (Figure 4A), ngn-3 (Figure 4B) and Pax-6 
(Figure 4C). Similar to c-met we also found c-kit on amylase producing exocrine 
cells (Figure 4D).
Co-expression with other pancreatic cell types
From the foregoing follows that nestin, c-met, and c-kit positive cells are clearly 
expressed by differentiating beta-cells in the islets. A striking observation is that 
almost all differentiating beta-cells express either nestin, c-met or c-kit, but that not 
all nestin, c-met, or c-kit expressing cells produce transcription factors associated 
with beta-cell differentiation. This implies that also other cell types in the neonatal 
islets do express nestin, c-met, or c-kit. Therefore, in a subsequent study we co-
stained nestin, c-met or c-kit with either the beta-cell speci¿ c markers Pdx-1 or 
insulin; the alpha-cell speci¿ c marker glucagon; the PP-cell and delta-cell speci¿ c 
markers pancreatic-polypeptide and somatostatin; the endothelial cell speci¿ c 
marker CD31; and nerve cell speci¿ c marker ȕ3-tubulin. This was done on puri¿ ed 
population of islet cells to obtain a more detailed analysis on cell level. 
We found that nestin positive cells do not express Pdx-1 (Figure 5A). A few nestin 
positive cells expressed pancreatic-polypeptide and somatostatin, but this was 
only a fraction of the pancreatic-polypeptide and somatostatin producing cells in 
the islets (Figure 5B). Another portion of the nestin expressing cells are CD31 
positive endothelial cell (Figure 5C) and ȕ3-tubulin expressing nerves in the islets 
(Figure 5D). Thus nestin is predominantly expressed on early differentiating beta-
cells, on endothelial cells, and on nerve cells in the islets.
Also c-met expression is not restricted to beta-cells. Although these cells xpress 
the beta-cell speci¿ c marker insulin (Figure 6A), we also found c-met on glucagon 
(Figure 6B) producing alpha-cells. The fast majority of c-met positive cells were 
CD31 positive endothelial cells (Figure 6C) and ȕ3-tubulin positive nerve cells 
(Figure 6D).
Similar to what we found on c-met positive cells, we found c-kit insulin producing 
cells (Figure 7A) and on glucagon producing cells (Figure 7B). However, the fast 
majority of c-kit bearing cells were CD31 positive endothelial cells (Figure 7C) 
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and ȕ3-tubulin positive nerve cells (Figure 7D). Due to technical reasons (see 
materials and methods), c-met and c-kit could not be doubled stained for pancreatic-
polypeptide and somatostatin.
Figure 5: Photomicrograph of cytospots of single cells from neonatal rat islets after 
immunostaining for nestin and mature islet cells, endothelial cells, and nerve cells. 
The sections were immunostained for nestin with Pdx-1, nestin with polypeptide and 
somatostatin, nestin with CD31, and nestin with b3-tubulin. Nestin positive cells do 
not express Pdx-1 (A). A few nestin positive cells express pancreatic-polypeptide and 
somatostatin (B). Except for islet cells, nestin positive cells also co-express CD31 (C), 
and b3-tubulin (D). Original magni¿ cation 200X
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Figure 6: Photomicrograph of cytospots of single cells from the neonatal rat islets 
after immunostaining for c-met and mature islet cells, endothelial cells, and nerve 
cells. The sections were immunostained for c-met with insulin, c-met with glucagon, 
c-met with CD31, and c-met with b3-tubulin. C-met positive cells express insulin (A) 
and glucagon (B). C-met positive cells also co-express CD31 (C), and b3-tubulin (D). 
Original magni¿ cation 200X
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Figure 7: Photomicrograph of cytospots of single cells from the neonatal rat islets after 
immunostaining for c-kit and mature islet cells, endothelial cells, and nerve cells. The 
sections were immunostained for c-kit with insulin, c-kit with glucagon, c-kit with CD31, 
and c-kit with b3-tubulin. C-met positive cells express insulin (A) and glucagon (B). C-kit 
positive cells also co-express CD31 (C), and b3-tubulin (D). Original magni¿ cation 200X
DISCUSSION
In the present study we show for the ¿ rst time that nestin, c-met, and c-kit are 
differentially expressed by beta-cells during the process of differentiation. Nestin 
is expressed by beta-cells in the early and mid-stage of differentiation and is absent 
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on beta-cells at the late or end stage of differentiation. C-met and c-kit are receptors 
that are found on all stages of differentiation of beta-cells.
The fast majority of studies on the role of nestin, c-met, and c-kit associate these 
bioactive molecules with islet-cell development, regeneration or with engineering 
and clonal expansion of beta-cell precursors for generation of beta-cells [1,3,5,6]. 
Only a few studies have focussed on the expression of these molecules on other 
cell types in the pancreas. We show that nestin, c-met, and c-kit is not only found 
on differentiating beta-cells but also on the non-endocrine cells in the islets, i.e. 
differentiating neonatal blood vessels and nerves. 
In 2001, Zulewski [3] demonstrated that nestin positive cells isolated from rat and 
human pancreatic islets can become beta-cells after appropriate stimulation in 
vitro. This however, was been debated by many who claimed that nestin positive 
cells were precursors for other cell types such as endothelial such but not for beta-
cells [16-19]. Our results illustrate however that nestin positive cells express both 
Islet-1 and ngn3 which have been previously been described as key regulators for 
pancreas development [20,21]. Our results corroborate the ¿ ndings of Zulewski [3] 
but do not necessarily debate the ¿ ndings of the other groups [16-19] since we also 
show that in the pancreatic islets nestin can be found not only in beta-cells but also 
in endothelial cells and in nerve cells. This implies that also in clonal expansion 
studies researchers may end up with nestin positive precursors that are not beta-cell 
precursors.
Interestingly also recent papers on human pancreata support our ¿ ndings and that 
of Zulewski on nestin in precursors of beta-cells. Eberhardt shows that outgrowing 
nestin positive cells from human islets express Islet-1 [22]. Furthermore it has been 
reported that in human foetal pancreas nestin positive cells co-express ngn3 in 
ducts, but not in the islets [23]. This is different in the postnatal rat pancreas since 
we found that nestin positive cells co-express ngn3 in the islets. 
The presence of progenitor cells in the pancreas has been questioned over the past 
few years. It has been thought that newly formed beta-cells are the product of beta-
cell replication [24], whereas others have pleaded for the existence of precursor cells 
and their contribution to newly formed beta-cells [25-31], however the existence 
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was not proven. This has recently changed by the pioneering publication of Xu et 
al. [32]. These authors demonstrate the presence of a multipotent progenitor cell 
in the stressed adult pancreas. Interestingly this multipotent progenitor cell is ngn3 
positive just as the pancreas derived multipotent c-met cells that can be clonally 
expanded and can differentiate towards insulin positive cell when infused in the 
pancreas [5]. Also our c-met and nestin positive cells are ngn3 positive and show 
similar distribution patterns in the pancreas as the cells described by Xu et al. [32]. 
C-met expression is believed to be crucial in beta-cell development [8]. It has 
been reported that isolated c-met positive cells from the pancreas can be clonally 
expanded to become insulin, glucagon or amylase positive [5]. Our results suggest 
that this multipotency is only observed in vitro after ex vivo manipulation and that 
this does not normally occur in vivo.
C-kit is mainly expressed in the endocrine alpha- and beta-cell fraction since the 
c-kit positive islet cells express Islet-1, ngn3 but also Pax6 which is associated 
with alpha-cell development [33]. To our best knowledge, c-kit has not been 
associated with alpha-cell differentiation, before. Also new from our data is the 
fact that c-kit is expressed on CD31 expressing endothelial cells and ȕ3-tubulin 
expressing nerve cells in the islets of the neonatal rat pancreas. This suggests that 
c-kit positive cells are not only involved in formation of endocrine cells, but also in 
formation of islet vasculature and innervation. It has been shown however that c-kit 
expression is essential for beta-cell development. Wang et al. [2] demonstrated 
that downregulation of c-kit results in decreased pdx-1 and insulin expression, 
suggesting downregulation of beta-cell differentiation [13]. 
Our study was not only undertaken to study the expression patterns of nestin, 
c-met, and c-kit cells in the differentiating endocrine pancreas, but also to con¿ rm 
that cells expressing these molecules are indeed precursors for beta-cells. Many 
are the efforts to ¿ nd ligands on precursor cells that allow selection of cells that 
have the potential to become beta-cell [4,5,34]. We demonstrate in this study that 
a portion of the nestin, c-met, and c-kit positive cells are indeed precursors for 
beta-cells. Therefore, a conceivable approach is to apply the extracellular proteins 
c-met and c-kit as a selection molecule for isolating precursor cells from the 
endocrine pancreas. Further puri¿ cation before clonal expansion is applied may 
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occur via deletion of the c-kit and c-met expressing endothelial cells and nerve 
cells. 
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